Hamilton Thorne (CVE:HTL) Shares Up 4.3% – Still a Buy?

Hamilton Thorne Ltd. (CVE:HTL) shares shot up 4.3% during mid-day trading on Tuesday . The company traded as high as C$1.45 and last traded at C$1.45. 25,700 shares traded hands during mid-day trading, a decline of 27% from the average session volume of 35,118 shares. The stock had previously closed at C$1.39.

Hamilton Thorne Price Performance

The company has a debt-to-equity ratio of 43.24, a current ratio of 2.04 and a quick ratio of 2.25. The stock’s fifty day moving average is C$1.45 and its 200-day moving average is C$1.45. The stock has a market cap of C$149.69 million, a PE ratio of 58.94 and a beta of 0.54.

Hamilton Thorne Company Profile

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.